Alterations in the coagulation markers did not show differences with the severity of COVID‐19 in Peruvian patients: A cross‐sectional single‐center study

Alterations in the coagulation markers did not show differences with the severity of COVID‐19 in Peruvian patients: A cross‐sectional single‐center study

Abstract Background and Aims COVID‐19 is a pandemic disease that can lead to altered lung function, systemic inflammatory events, and altered coagulation. During severe stages of the disease, changes in coagulation homeostasis increase, leading to thrombosis, and increased risk of death. In this cro...

Full description

Bibliographic Details
Main Authors: Jeel Moya‐Salazar, Liliana Y. Cóndor, Nahomi Zuñiga, Alexis Jaime‐Quispe, Belén Moya‐Salazar, Karina Chicoma‐Flores, Betsy Cañari, Hans Contreras‐Pulache
Format: Article
Language:English
Published: Wiley 2023-03-01
Series:Health Science Reports
Subjects:
coagulation
COVID‐19
D dimer
fibrinogen
prothrombin time
SARS‐CoV‐2
Online Access:https://doi.org/10.1002/hsr2.1105

Internet

https://doi.org/10.1002/hsr2.1105

Similar Items